Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Deactivating the alarm

26.04.2010
Therapeutic strategies that block inflammatory response to islet cell transplantation may accelerate treatment of diabetic patients

For patients with insulin-dependent diabetes mellitus, the only route to full recovery without daily injections of insulin is by transplantation of pancreatic islet cells. This can be achieved non-surgically via injection of donor cells into the liver, but such treatment also elicits a vigorous negative response from the body.

“Transplantation tolerance can be controlled by immunosuppressive drugs such as FK506,” says Masaru Taniguchi of the RIKEN Research Center for Allergy and Immunology in Yokohama. “However, transplanted islets are rejected soon after transplantation even with the use of FK506.” The mechanism for this rejection is unknown, and patients must typically receive several injections from multiple donors for transplantation to succeed.

High-mobility group box 1 (HMGB1) was first identified as a DNA-binding factor in the cell nucleus, but it is also secreted by immune cells as an apparent trigger for inflammation in response to tissue damage. Taniguchi’s team recently joined forces with Yohichi Yasunami at Fukuoka University to demonstrate the impact of this protein on transplanted islet survival.

They produced diabetic mice by treating the animals with an islet-killing drug, and then transplanted varying numbers of donor islet cells. Animals receiving 200 cells normally developed diabetic symptoms, but these could be averted by simultaneous treatment with HMGB1-blocking antibodies. This treatment also prevented accumulation of immune cells in the liver and countered the production of inflammatory cytokines—typical outcomes of islet transplantation.

The researchers were surprised to note that HMGB1 expression was highly specific to islet cells, with protein levels 20-fold higher than any other organ or tissue examined, further supporting its particular role in islet rejection. In fact, they noted two strong peaks in plasma levels of HMGB1 in transplant recipients: one 24 hours after chemical destruction of islets, and another 6 hours after islet injection. These results suggest that islet stress or damage directly triggers HMGB1 secretion, which in turn activates the inflammatory response pathways that initiate destruction of the transplanted cells.

These findings provide strong hope for improving transplant efficiency. “We can use antibodies in humans without any side effects, because HMGB1 is not present in the serum under physiological conditions,” says Taniguchi, who adds that Yasunami’s team is now exploring clinical strategies based on this approach. However, Taniguchi also hopes to develop chemical inhibitors that preemptively block HMGB1 secretion by donor cells prior to transplantation. “This is ideal,” he says, “because then we do not need to treat patients with any drugs or antibodies.”

The corresponding author for this highlight is based at the Laboratory for Immune Regulation, RIKEN Research Center for Allergy and Immunology

Journal information

1. Matsuoka, N., Itoh, T., Watarai, H., Sekine-Kondo, E., Nagata, N., Okamoto, K., Mera, T., Yamamoto, H., Yamada, S., Maruyama, I. et al. High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. The Journal of Clinical Investigation 120, 735–743 (2010).

gro-pr | Research asia research news
Further information:
http://www.riken.jp
http://www.rikenresearch.riken.jp/eng/research/6238
http://www.researchsea.com

Further reports about: Allergy Deactivating HMGB1 Immunology RIKEN immune cell immunosuppressive drug islet cells

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>